Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tubercle bacilli retain pathogenicity after seven weeks chemotherapy.

J T Cassidy

    The Medical Journal of Australia
    |May 30, 1981
    PubMed
    Summary

    Tuberculosis patients on anti-tuberculous therapy may remain infectious for over seven weeks, challenging the assumption of rapid non-infectiousness. This study highlights the persistent pathogenicity of tubercle bacilli despite treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A bibliometric analysis of the 50 most cited articles on acromioclavicular joint reconstruction.

    Musculoskeletal surgery·2025
    Same author

    YouTube provides poor information regarding anterior cruciate ligament injury and reconstruction.

    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2017
    Same author

    Selective IgA deficiency in children and adults with systemic lupus erythematosus.

    Lupus·2007
    Same author

    Progress in diagnosis and understanding chronic pain syndromes in children and adolescents.

    Adolescent medicine (Philadelphia, Pa.)·2000
    Same author

    Quo vadis? Whither goest thou, rheumatologist?

    The Journal of rheumatology. Supplement·2000
    Same author

    Medical management of children with juvenile rheumatoid arthritis.

    Drugs·1999

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pulmonology

    Background:

    • Active pulmonary tuberculosis patients on anti-tuberculous drugs are generally presumed to become noninfectious quickly.
    • Several factors, including reduced cough, drug concentration in sputum droplets, and decreased bacillary load, are thought to contribute to this rapid non-infectiousness.

    Purpose of the Study:

    • To investigate the duration of tubercle bacilli pathogenicity in sputum from patients undergoing anti-tuberculous therapy.
    • To challenge the established belief regarding the rapid loss of infectivity in tuberculosis patients receiving treatment.

    Main Methods:

    • Inoculation of sputum from patients on anti-tuberculous therapy into guinea pigs.
    • Monitoring the pathogenicity of Mycobacterium tuberculosis in animal models over time.

    Main Results:

    • Guinea pig inoculation demonstrated that tubercle bacilli retained pathogenicity for seven weeks or longer in some cases.
    • This finding contrasts with the widely accepted notion of rapid non-infectiousness in treated tuberculosis patients.

    Conclusions:

    • The persistence of tubercle bacilli pathogenicity for extended periods challenges current understanding of tuberculosis treatment efficacy.
    • Further research is needed to understand the factors influencing prolonged infectivity and to refine treatment guidelines for tuberculosis.

    Related Experiment Videos